Single-dose regimen of high dosage investigational sIPV
PRO-sIPV-1001
Phase 2 mab completed
Quick answer
Single-dose regimen of high dosage investigational sIPV for Poliomyelitis is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Poliomyelitis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed